Approvals (Drugs@FDA)

DAPSONE

ALEMBIC · DAPSONE

ANDA213414Generic (ANDA)Prescription
Open FDA's page for this record
Application number
ANDA213414
Sponsor name
ALEMBIC
Submissions
  1. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    20260625
    Review priority
    STANDARD
    Submission class code
    UNKNOWN
Products
  1. Product number
    001
    Reference drug
    No
    Brand name
    DAPSONE
    Reference standard
    No
    Dosage form
    GEL
    Route
    TOPICAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      DAPSONE
      Strength
      5%
Harmonized identifiers (openFDA)
Application number
ANDA213414
Brand name
DAPSONE
Generic name
DAPSONE
Manufacturer name
Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Limited
Product NDC
62332-551, 46708-551
Product type
HUMAN PRESCRIPTION DRUG
Route
TOPICAL
Substance name
DAPSONE
RxCUI
607295
SPL ID
d9849120-ccaa-4820-8e8d-3a8c7d809ffb, 1a5c37bb-155e-4a03-afc6-4a4ef1f9dce1
SPL set ID
7249f655-1d8e-482a-889a-1e7e1a19500c, 0f1301f6-884d-4fc7-a5b2-421b2375b985
Package NDC
62332-551-60, 62332-551-90, 62332-551-30, 46708-551-60, 46708-551-90, 46708-551-30
Nui
N0000175881, M0020791
Pharm class epc
Sulfone [EPC]
Pharm class cs
Sulfones [CS]
UNII
8W5C518302
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.